Related references
Note: Only part of the references are listed.US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States
Rajiv Saran et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2020)
Loss of Roundabout Guidance Receptor 2 (Robo2) in Podocytes Protects Adult Mice from Glomerular Injury by Maintaining Podocyte Foot Process Structure
Anna Pisarek-Horowitz et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
Regulation of the Actin Cytoskeleton in Podocytes
Judith Blaine et al.
CELLS (2020)
Differentiating Primary, Genetic, and Secondary FSGS in Adults: A Clinicopathologic Approach
An S. De Vriese et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
SLIT2/ROBO2 signaling pathway inhibits nonmuscle myosin IIA activity and destabilizes kidney podocyte adhesion
Xueping Fan et al.
JCI INSIGHT (2016)
Inhibitory Effects of Robo2 on Nephrin: A Crosstalk between Positive and Negative Signals Regulating Podocyte Structure
Xueping Fan et al.
CELL REPORTS (2012)
Clinical trial of focal segmental glomerulosclerosis in children and young adults
Debbie S. Gipson et al.
KIDNEY INTERNATIONAL (2011)
A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis
Howard Trachtman et al.
KIDNEY INTERNATIONAL (2011)
Phase 1 Trial of Adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) Study Group
Melanie S. Joy et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)